Prospective Treatment Study of Catatonia Patients

Stopped early · Not applicable

Conditions studied: Catatonia

In brief

The purpose of this treatment study is to compare the effectiveness of different electrode placements used in Electroconvulsive Therapy (ECT) in the treatment of catatonia. In this study Electroconvulsive Therapy will be compared to medications used in the treatment of catatonia. Medications will be administered by the primary team as part of standard of care. Medications are not primarily being used as a part of this research study. This treatments study, will be able to compare response rate of catatonia to right unilateral electroconvulsive treatment (RUL ECT) and Bilateral electroconvulsive treatment (BL ECT). Also having a control group of catatonia patients, which will not be treated with ECT will provide additional information on early ECT treatment of Catatonia.

Key facts

Study ID

NCT02734498

Run by

Wake Forest University Health Sciences

People needed

2

Starts

2017-01-01

Expected to finish

2017-03-19

Last updated by the study team

2019-07-02

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients admitted to WFBMC Inpatient Psychiatry unit with catatonia who are clinically eligible for ECT.
• Clinical catatonia as evidenced by a Bush-Francis Catatonia Rating Scale (BFCRS) score of 4 or more

You may not qualify if…

• Pregnant women
• Patients with any of the following medical conditions which are contraindications for ECT:
• Pheochromocytoma
• History of stroke within the past 3 months
• Cardiac conduction defects
• Cerebral or aortic aneurysms

Where it is running

• Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.